Online Pharmacy


Buy Online

Advair
Diskus Generic (Fluticasone / Salmeterol)
Fluticasone is a steroid. It prevents
the release of substances in the body that cause inflammation. Salmeterol
is a bronchodilator. It works by relaxing muscles in the airways to improve
breathing. Advair Diskus (Fluticasone and Salmeterol) inhalation is used to
prevent asthma attacks.
Albuterol
Generic (Salbutamol)
Albuterol works by relaxing muscles
in the airways to improve breathing. Albuterol is used to treat bronchospasm
(wheezing, shortness of breath) associated with reversible obstructive airway
disease such as asthma.
Alvesco
Combo Generic (Ciclesonide / Formoterol)
Alvesco Combo (Ciclesonide / Formoterol)
is used for long-term treatment of asthma. It may be used to prevent breathing
problems in certain patients, including patients with nighttime asthma, or
breathing problems caused by exercise.
Beclovent
Generic (Beclomethasone)
Beclovent (Beclomethasone) is a corticosteroid
used to treat asthma. This medicine is also used to prevent asthma attacks.
It will not stop an asthma attack once one has started.
Brethine
Generic (Terbutaline)
Brethine (Terbutaline) is a bronchodilator
used to treat or prevent the symptoms of asthma, emphysema, and other breathing
conditions.
Flovent
Generic (Fluticasone)
Flovent (Fluticasone) is a corticosteroid
used to treat asthma. This medicine is also used to prevent asthma attacks.
It will not stop an asthma attack once one has started.
Flutiform
Generic (Fluticasone / Formoterol)
Preventing asthma attacks. Flutiform
(Fluticasone / Formoterol) will not stop an asthma attack once one has started.
It may also be used to treat other conditions as determined by your doctor.
Flutiform (Fluticasone / Formoterol) is a corticosteroid.
Foradil
Generic (Formoterol)
Foradil is a long-acting bronchodilator
that relaxes muscles in the airways to improve breathing. Foradil is used
to prevent bronchospasm in people with reversible obstructive airways disease,
including symptoms of night-time asthma.
Proventil
Generic (Albuterol)
Proventil (Albuterol / Salbutamol
SR) is a bronchodilator used to treat or prevent the symptoms of asthma, emphysema,
and other breathing conditions. This medicine is also used to prevent the
symptoms of exercise-induced asthma.
Pulmicort
Generic (Budesonide)
Pulmicort (Budesonide) is a corticosteroid
used to prevent bronchial asthma. It is not used to relieve an asthma attack.
Serevent
Generic (Salmeterol)
Serevent (Salmeterol) is a beta receptor
stimulant used to prevent or minimize problems in persons with breathing difficulties
including asthma and chronic obstructive disorders of the lungs such as chronic
bronchitis or emphysema. It works by opening the air passages in the lungs
to improve breathing. It will not stop an asthma attack once one has started.
Singulair
Generic (Montelukast)
Singulair (Montelukast) is used for
the prevention and long-term treatment of asthma. It is also used to treat
hay fever (seasonal allergic rhinitis). Montelukast works by blocking substances
in the body called leukotrienes.
Symbicort
Generic (Budesonide / Formoterol)
Long-term treatment of asthma and
chronic obstructive pulmonary disease (COPD) in certain patients. Symbicort
(Budesonide / Formoterol) is a combination of a synthetic corticosteroid and
a long-acting beta-agonist bronchodilator.

|
 |
Asthma News
 |

photo credit : arsheffield |
 |
Traffic
linked to 'worsening' child asthma
An Australian study
into childhood asthma has sounded an alarm over city living,
with even apparently safe levels of traffic pollution found
to exacerbate the respiratory condition. Researchers assessed
the cases of more than 600 children and adolescents who between
2002 and 2006 were rushed to West Australian hospitals suffering
a serious asthma attack.
Air-quality records
for the period leading up to each attack were checked, and
this revealed a strong trend of rising traffic-related pollutants
ahead of each hospital trip. Advertisement: Story continues
below Atmospheric levels of nitrogen dioxide and carbon monoxide
were often elevated on the day before a child suffered the
asthma attack.
An epidemiologist
at the University of WA, Gavin Pereira, said the study showed
how traffic pollution was a major factor in the "worsening
of this respiratory condition" in children. There were
other troubling implications, he said, as Australia had far
more traffic-intensive cities than Perth and the effect was
seen even as air quality was deemed to meet safety benchmarks.
"This study
was conducted in Perth, Western Australia ... pollution levels
are generally quite good in Perth," Mr Pereira told AAP.
"I've looked at studies from California, for example,
and their pollution levels are much higher than here.
"And for our
study to have observed an effect when we have met air-quality
guidelines is quite remarkable." The effect was most
pronounced in asthmatic children aged under four, according
to the research as detailed in the latest edition of the Medical
Journal of Australia.
Read
the full article at Sydney Morning Herald - Click Here |
 |
 |
 |
Bronchial
Thermoplasty Non-Drug Treatment For Severe Asthma
The Boston Scientific
Corporation has released that its acquiring subsidiary Asthmatx,
Inc., introduced two year findings from the Asthma Intervention
Research 2 (AIR2) Trial evidence of the long term safety and
effectiveness of bronchial thermoplasty in adult patients
who have severe asthma. The findings were given by Dr. Mario
Castro, Professor of Medicine and Pediatrics, Washington University
School of Medicine and Principal Investigator of the AIR2
trial, at the CHEST 2010 meeting of the American College of
Chest Physicians in Vancouver.
The findings had
emphasized main long term results showing the constancy of
safety and effectiveness of bronchial theromplasty established
on the relative amount of patients enduring severe irritations
and 84% decline in emergency room visits for respiratory symptoms
noted at one year in patients treated with BT in comparison
to a control group which received pseudo procedure out to
two years.
Dr. Castro stated
it was gratifying to witness the valuable benefits of BT remain
up to two years in patients with severed asthma who were part
of the study. These clinical important improvements, combined
with constant and maintained long term safety, validate that
BT as a meaningful new treatment choice for patients with
severe asthma who have poor control regardless of taking high
doses of corticosteroids and long acting bronchodilators.
BT is a bronchoscopic
procedure usually done under medium sedation with patients
usually going home the same day. The Alair® System gives
exact controlled thermal energy to the airway wall to decrease
extra airway smooth muscle. The procedure reduces the airways
ability to tighten therefore decreasing the occurrences and
severity of attacks.
Positive safety and
effectiveness information at one year post-bronchial thermoplasty
were published in the January 2010 issue of American Journal
of Respiratory and Critical Care Medicine.
Read
the full article at Examiner - Click Here |
 |
 |
 |
Canadian
Kids Seem More Likely to Be Sidelined by Asthma
Canadian children
with asthma feel more isolated from their peers than children
with asthma in other countries surveyed, according to a new
study.
Compared to kids
with asthma in five other countries, Canadian children with
asthma were more likely to feel sad (18.2 percent versus 12.1
percent) and left out (13.2 percent versus 8.4 percent). They
also were less likely to feel "no different" than
their peers (31.5 percent versus 51.4 percent). More than
half of the Canadian kids surveyed considered asthma to be
a barrier to sports (54.1 percent) while only 35.2 percent
of kids from other countries felt that way.
"The data suggest
that Canadian children with asthma may be missing out on being
involved in sports because they feel excluded," lead
researcher Dr. William Carroll, of Derbyshire Children's Hospital
in the United Kingdom, said in a news release from the American
College of Chest Physicians.
"It's also possible
that sports involving cold air, such as ice hockey, which
is popular in Canada, are more difficult for those with asthma,"
he added.
Carroll and colleagues
from Switzerland and the Netherlands interviewed 228 Canadian
parents of children with asthma and 159 Canadian children
aged 4 to 15 who had asthma. They also examined parent and
child interviews conducted in Greece, Hungary, the Netherlands,
South Africa and the United Kingdom.
Read
the full article at Business Week - Click Here |
 |
 |
 |
more
Asthma News |
 |
|
 |

Asthma News

Mold Increases Asthma Risk in Babies
(Ivanhoe Newswire) â??Nine percent of American children will develop asthma at some point during their childhood. However, children from poor, urban families have higher chances of developing it. According to a new study, babies who live in moldy homes are three times more likely to develop asthma by age seven. "Early life exposure to mold seems to play a critical role in childhood asthma ...
Poorly controlled asthma costly, study finds
Poorly controlled asthma more than doubles health-care costs associated with the disease and threatens educational achievement through a dramatic increase in school absence, according to researchers. It highlights the toll that poorly controlled asthma takes on children. It also points to an opportunity.
Mold Exposure During Infancy Increases Asthma Risk
Infants who live in "moldy" homes are three times more likely to develop asthma by age 7â??an age that children can be accurately diagnosed with the condition. Study results are published in the August issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI). "Early life exposure to mold seems to play a critical role ...
Mold Exposure in Infancy Raises Asthma Risk
Title: Mold Exposure in Infancy Raises Asthma Risk Category: Health News Created: 8/3/2011 11:01:00 AM Last Editorial Review: 8/3/2011

|